arBtrage CAPITALIZING MARKETS checking… Sign in

Keros Therapeutics, Inc.

KROS Health Care Biotechnology: Pharmaceutical Preparations
$10.30
▼ -4.4% Today
as of Jun 7, 07:19 ET
Last 30 days -9.41% Apr 28 → Jun 05
$9.74 $10.36 $10.99 $11.62 $12.24 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$10.78
High
$10.84
Low
$10.24
Volume
$139,590
Avg Vol
$573,569
Mkt Cap
$225M
P/E (TTM)
Beta
52w High
$22.55
52w Low
$9.79
Div Yield
Shares Out
$20M

Overview

52-week range
$9.79
$23
4% of range
Avg surprise (last 2)
+18,134%
Avg reaction (last 2)
-6.9%
0% positive
Latest IV / EM
350%
EM ±48.5% · $10 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.41$-0.15$1.11$2.36$3.62 Actual $-1.27Actual $-1.33Actual $-1.21Actual $-1.25Actual $-1.41Actual $3.62Est $-0.01Actual $-0.76Actual $-0.18Actual $-1.21Est $-0.92 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-53M$16M$84M$153M$222M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $-1.21 $-0.92 -31.5% -133.4% -8.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.18 financials
Mon Jun 30, 2025Jun 2025 $-0.76 financials
Tue May 6, 2025Mar/2025 $3.62 $-0.01 +36,300% -5.5% earnings
Mon Sep 30, 2024Sep 2024 $-1.41 financials
Sun Jun 30, 2024Jun 2024 $-1.25 financials
Sun Mar 31, 2024Mar 2024 $-1.21 financials
Sat Sep 30, 2023Sep 2023 $-1.33 financials
Fri Jun 30, 2023Jun 2023 $-1.27 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$32,000$14M$18M$211M$0$0
Cost of revenue
Gross profit
Operating income$-26M$-15M$-40M$152M$-59M$-50M
Net income$-24M$-7M$-31M$148M$-53M$-45M
EPS (diluted)$-1.21$-0.18$-0.76$3.62$-1.41$-1.25

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$281M$287M$693M$690M$721M$560M$531M$406M
Inventory
Total current assets$291M$315M$719M$733M$760M$589M$552M$433M
Total assets$312M$338M$743M$757M$785M$616M$579M$455M
Long-term debt
Total liabilities$27M$35M$39M$50M$56M$44M$46M$34M
Total equity$286M$303M$704M$707M$729M$572M$533M$421M

Implied volatility — last 90 days

345%347%350%352%355% Jun 07 — IV 350% · EM ±48.5%

Sector peers